We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+23.43%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.4B
AUM Growth
-$5.58B
Cap. Flow
-$3.87B
Cap. Flow %
-23.65%
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$114M
2
BMY icon
Bristol-Myers Squibb
BMY
+$109M
3
TT icon
Trane Technologies
TT
+$106M
4
MSFT icon
Microsoft
MSFT
+$104M
5
MA icon
Mastercard
MA
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 13.89%
3 Financials 11.27%
4 Consumer Discretionary 8.92%
5 Industrials 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBK icon
326
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$8.65M 0.05%
43,357
-5,616
-11% -$1.01M
EEM icon
327
iShares MSCI Emerging Markets ETF
EEM
$28.1B
$8.65M 0.05%
216,278
-7,702
-3% -$288K
PNW icon
328
Pinnacle West Capital
PNW
$12.9B
$8.62M 0.05%
117,607
+40,143
+52% +$3.03M
NJR icon
329
New Jersey Resources
NJR
$6.12B
$8.57M 0.05%
262,588
+252,936
+2,621% +$8.38M
QQQ icon
330
Invesco QQQ Trust
QQQ
$446B
$8.51M 0.05%
34,389
-1,459
-4% -$327K
MO icon
331
Altria Group
MO
$127B
$8.45M 0.05%
215,300
-1,160,749
-84% -$45.3M
IEMG icon
332
iShares Core MSCI Emerging Markets ETF
IEMG
$147B
$8.28M 0.05%
173,878
-17,943
-9% -$801K
STAG icon
333
STAG Industrial
STAG
$7.78B
$8.26M 0.05%
281,537
+281,215
+87,334% +$7.4M
EFX icon
334
Equifax
EFX
$22.3B
$8.15M 0.05%
47,410
+671
+1% +$99.4K
OTTR icon
335
Otter Tail
OTTR
$3.95B
$8.05M 0.05%
207,512
+207,333
+115,828% +$8.73M
GE icon
336
GE Aerospace
GE
$374B
$7.64M 0.05%
224,460
+14,078
+7% +$475K
GS icon
337
Goldman Sachs
GS
$306B
$7.63M 0.05%
38,625
+5,927
+18% +$1.11M
ADSK icon
338
Autodesk
ADSK
$51.1B
$7.62M 0.05%
31,840
+30,293
+1,958% +$5.95M
G icon
339
Genpact
G
$5.9B
$7.61M 0.05%
208,430
+66,229
+47% +$2.24M
IWB icon
340
iShares Russell 1000 ETF
IWB
$47.9B
$7.53M 0.05%
43,870
+319
+0.7% +$51.6K
AIR icon
341
AAR Corp
AIR
$5.41B
$7.49M 0.05%
362,349
-94,203
-21% -$1.82M
ORA icon
342
Ormat Technologies
ORA
$5.98B
$7.27M 0.04%
114,527
-28,237
-20% -$1.85M
AZN icon
343
AstraZeneca
AZN
$267B
$7.18M 0.04%
67,916
-9,086
-12% -$938K
NVS icon
344
Novartis
NVS
$304B
$6.89M 0.04%
78,884
-22,151
-22% -$1.91M
MDY icon
345
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$6.8M 0.04%
20,962
+730
+4% +$221K
OGE icon
346
OGE Energy
OGE
$10.3B
$6.73M 0.04%
221,604
-11,598
-5% -$359K
IWV icon
347
iShares Russell 3000 ETF
IWV
$19.5B
$6.7M 0.04%
37,193
-16,511
-31% -$2.8M
LKQ icon
348
LKQ Corp
LKQ
$6.86B
$6.67M 0.04%
254,776
-257,191
-50% -$6.33M
BDX icon
349
Becton Dickinson
BDX
$45.4B
$6.67M 0.04%
28,577
-3,027
-10% -$730K
AWK icon
350
American Water Works
AWK
$27.1B
$6.6M 0.04%
51,297
-327
-0.6% -$40.7K

Similar funds

Glenmede Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.

  • Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
  • Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
  • Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
  • Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
  • Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
  • Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
  • Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.